Merck is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion as the pharma company looks to diversify its pipeline. trib.al/YJquhNW

It's been 20 years since focused ultrasound was approved as a treatment for uterine fibroids. Why is this groundbreaking treatment still hard to access for most U.S. women? trib.al/ouw0iya

Unless Medicaid raises its payments to rural psychiatrists, mental health clinics across the heartland will disappear, and with it the mental health care for the patients they serve. trib.al/mIkuH2g

GLP-1 drugs are transforming the treatment of diabetes and obesity. But many Black Americans worry that their community is being left behind. trib.al/cLf44bz

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer. trib.al/dKfmaaF

Join STAT Brand Studio tomorrow, May 29, for a virtual event 'Manufacturing Concepts for Antibody-Drug Conjugates.' Learn more here: trib.al/tuyoUT4 #STATBrandStudio

High temperatures are especially dangerous for those with cardiovascular and chronic disease — but they begin affecting human lives even before birth. trib.al/38Jwnf2

Here's your #ASCO2024 preview: a promising solid tumor CAR-T, an AI patient navigator, and improving palliative care. trib.al/IWxzpL7

“It’s almost like making a deal with the devil. ... When you have to do something you really don’t want to do, but at the same time you really need something.'

The doctor would treat her sickle cell pain crisis — if she promised not to get an abortion. trib.al/JLg1p8j

Must read: second installment of Eric Boodman's investigation into reproductive care for sickle cell patients.
I will steal this line next time I am recommended Tylenol for gyno pain! 'Taking a Tylenol was like using a squirt gun against a house fire.' statnews.com/2024/05/28/sic…

Advances in gene therapy could eventually 'cure' many forms of congenital deafness. But deaf people are feeling a familiar dread: Are we endangered? trib.al/pQQFLcC

STAT reporters Angus Rohan Chen Matthew Herper Adam Feuerstein ✡️ all over #ASCO24 in Chicago, where clinicians expect to see new science or research that might advance patient care, cancer treatments, and health equity.
statnews.com/2024/05/27/can… via STAT

Some STAT @ #ASCO24 housekeeping notes:

- I will be joined in Chicago by my STAT reporter colleagues Matthew Herper and Angus Rohan Chen

- We will write stories, of course, but also a free, daily newsletter that will be delivered to your inbox at 4:30 pm EDT during the meeting. Sign

Get a preview of STAT's coverage for #ASCO2024 , from events to a pop-up newsletter to the buzziest abstracts that will be presented. trib.al/wBD7Mvt

A new dark money group called “Defend our DNA” has started to run some social media ads supporting the BIOSECURE Act. trib.al/lTqCPmQ

In the last week: —Agios Pharmaceuticals announced a $905 million purchase with Royalty Pharma —Pheon Therapeutics raised a $120 million Series B —SixPeaks Bio came out of stealth with $110 million in funding. trib.al/GGOPoEc

My latest STAT: Advances in gene therapy could eventually 'cure' many forms of congenital deafness. But many deaf people don't want this. They worry that this treatment will deplete their communities and make them an 'endangered species.'

statnews.com/2024/05/28/gen…

Almost a dozen pharmaceutical companies have lost sensitive customer data due to a supply chain cyberattack that trickled down from Cencora. trib.al/Z0Ywx4D

Methadone clinics are being pressured to open up access to this form of addiction treatment. But at a conference, industry leaders pushed back. trib.al/vW0d8Ba

$INSM Airway disease drug from Insmed succeeds in one of the year’s most anticipated trials statnews.com/2024/05/28/ins… via Andrew Joseph